期刊
JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES
卷 35, 期 11, 页码 1459-1480出版社
TAYLOR & FRANCIS INC
DOI: 10.1080/10826076.2011.619037
关键词
degradation; in vitro release study; mass spectroscopy; nuclear magnetic resonance; solid lipid nanoparticle; vaginal formulation
A stability-indicating high-performance thin-layer chromatographic (HPTLC) method was developed and validated for quantifying Itraconazole (Itz) in bulk drug, marketed formulation, and an in-house formulation comprised of lipidic-nano particle incorporated into vaginal gel. Aluminum plates precoated with silica gel 60 F-254 were used for TLC with Toulene:Ethyl acetate: Ammonia (1:5:0.1 v/v) as a mobile phase. The densitometric analysis was carried out at 266 nm using a Camag TLC scanner that generated compact spots for Itz (R-f=0.77 +/- 0.02). The regression analysis data for the calibration curve exhibited good linearity (r(2) = 0.996 +/- 0.0058). The LOD and LOQ values were found to be 14.29 ng spot(-1) and 43.31 ng spot(-1), respectively, while their recovery (99.65-100.23%) and precision (1.47%) were found to be satisfactory. Itraconazole was also subjected to forced stress conditions such as hydrolysis (acid and alkali), oxidation, dry and wet heat degradation, and photo degradation. The degradants were further characterized by NMR and Mass spectroscopy and compared with neat drug. Statistical analysis revealed that the developed method has potential for routine analysis of Itz in various formulations. It is well suited for quality control and study of pharmaceutical parameters such as release profile, loading, and entrapment in lipidic nanoparticle formulation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据